The Bayer group has announced plans to expand its operations in Asia, predicting annual sales of over €11bn in the region by 2015.

Management board chairman Dr Marijn Dekkers told delegates at Bayer’s international conference that the company aims to achieve a more than 60% increase in sales in Asia by 2015.

Go deeper with GlobalData

Data Insights

The gold standard of business intelligence.

Find out more

"We have made capital expenditures of €3.4bn in Asia over the past ten years, creating a basis for outperforming market growth in this region," said Dekkers.

Sales in Greater China are planned to account for some €6bn as Bayer expands its production, distribution network and research facilities in the country over the coming years.

In Asia, Bayer achieved sales of €6.9bn in 2010, including €2.9bn in Greater China, and anticipates further growth in Asia in 2011.

GlobalData Strategic Intelligence

US Tariffs are shifting - will you react or anticipate?

Don’t let policy changes catch you off guard. Stay proactive with real-time data and expert analysis.

By GlobalData

Pharmaceutical Technology Excellence Awards - Have you nominated?

Nominations are now open for the prestigious Pharmaceutical Technology Excellence Awards - one of the industry's most recognised programmes celebrating innovation, leadership, and impact. This is your chance to showcase your achievements, highlight industry advancements, and gain global recognition. Don't miss the opportunity to be honoured among the best - submit your nomination today!

Nominate Now